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We assess the genetic relationships between 49 HIV-1 group O strains from 24 and 25 patients living in Cameroon and
France, respectively. Strains were sequenced in four genomic regions: gag (p24) and three env regions (C2-V3, gp41, and for
22 C2-gp41). In each of the genomic regions analyzed, the genetic diversity among the group O strains was higher than that
exhibited by group M. We characterize three major group O phylogenetic clusters (O:A, O:B, and O:C) that comprised the
same virus strains in each of the genomic regions analyzed. The majority of strains cluster in O:A, a cluster previously
identified by analysis of pol and env sequences. Group O recombinants were also identified. Importantly, the distinction
between these three major group O clades was weak compared to the strong clustering apparent in the global group M
phylogenetic tree that led to the identification of subtypes. Thus, these clusters of group O viruses should not be considered
as equivalent to the group M subtypes. This difference between the pattern of group O and the global group M diversity, both
taking into account the pandemic status of the group M subtypes and the comparatively small number of group O-infected
individuals (the majority being from Cameroon), indicates that the group O phylogeny primarily represents viral divergence
in the Cameroon region, analogous to group M viral diversity present in the Democratic Republic of Congo. © 2002 ElsevierINTRODUCTION
In the early 1990s, unusual HIV strains isolated from
patients of Central African origin were found to be
highly divergent to previously described HIV-1 or HIV-2
strains (Charneau et al., 1994; De Leys et al., 1990;
Gurtler et al., 1994; Vanden Haesevelde et al., 1994).
Complete genomic sequencing of these viruses revealed
that they share the same genetic structure as previously
characterized HIV-1 strains, notably the presence of vpu
and the absence of vpx, and in phylogenetic analysis
they clustered in the HIV-1/SIVcpz lineage. HIV-1 viruses
were thus divided into two groups: group M (for main) to
describe the lineage comprising the vast majority of
strains responsible for the global HIV/AIDS epidemic,
and group O (for outlier) to describe the lineage com-
prising the then new and highly divergent HIV-1 strains,
mainly found in patients of Central African origin. More
recently in Cameroon a new “non-M/non-O” lineage
(named group N) was identified (Simon et al., 1998).
1 To whom correspondence and reprint requests should be ad-
dressed at CIRMF, Department of Virology, BP 769, Franceville, Gabon.
Fax: 241 67 70 87 or 241 67 72 95. E-mail: p.roques@cirmf.sci.ga, orThese three HIV-1 lineages (groups M, N, and O) are
each inferred to correspond to separate zoonotic trans-
mission events of SIVcpz from the chimpanzee to hu-
mans (Corbet et al., 2000; Gao et al., 1999). Group M has
been further classified into “subtypes” which correspond
to the approximately equidistant lineages, 9 of which are
currently identified (A–D, F–H, J, and K) (Robertson et al.,
2000).
Group O has mainly been investigated by serological
studies (Ayouba et al., 2001; Nkengasong et al., 1993;
Peeters et al., 1997; Zekeng et al., 1997), so very little is
known about the evolution of this unusual HIV-1 lineage.
What is clear is that unlike the group M pandemic, group
O infections are primarily focused on Cameroon with
relatively low prevalence (Ayouba et al., 2001; Mauclere
et al., 1997), while in neighboring countries: Chad,
Congo, Equatorial Guinea, Gabon, Niger, and Nigeria,
prevalence is even lower (Hunt et al., 1997; Kabeya et al.,
1995; Peeters et al., 1997). Group O antibodies have also
been detected in other African countries: Be´nin, Kenya,
Senegal, and Togo (Heyndrickx et al., 1996; Kane et al.,
2001; Peeters et al., 1997; Songok et al., 1996). The group
O infections which have been documented in the Euro-
pean countries of France (Charneau et al., 1994; Lous-Science (USA)
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sert-Ajaka et al., 1994), Belgium (De Leys et al., 1990),
Germany (Hampl et al., 1995), and Spain (Mas et al.,
0042-6822/02 $35.00nce; g© 2002 Elsevier Science (USA)
All rights reserved.
259
1996), and in the United States (Rowe, 1996; Sullivan et
al., 1997, 2000) are mainly found in patients who have
direct links with Central Africa.
In this study we compared the phylogenetic relation-
ships of HIV-1 group O strains obtained from patients
living in Cameroon and France with previously described
group O viruses. The newly derived sequences were
obtained from four different genomic regions: gag (p24)
and three regions in env (C2-V3, gp41, and C2-gp41). The
aims of this study were to make a direct comparison
between the diversity of HIV-1 groups O and M, the
phylogenetic substructure of group O and previously
inferred group O trees, and to assess whether the evo-
lution of group O has resulted in a similar tree structure
to group M, i.e., discrete subtype-like clusters of viruses.
RESULTS
Sequences of the O isolate show a high diversity
We obtained sequences for the 49 isolates in three
genomic regions (gag p24, partial env gp41, and C2-V3)
and for 22 C2-gp41 env sequences. Group O sequences
which had been sequenced in the same gag, C2-V3,
gp41, and C2-gp41 regions were retrieved from GenBank.
Sequences shorter than 200 nucleotides were excluded
from the analysis resulting in 21 gag, 23 C2-V3, 38 gp41,
and 10 C2-gp41 sequences for alignment with the newly
derived sequences. An amino acid sequence alignment
was used as an exact guide for the nucleotide alignment.
Several sequences from GenBank contained single in-
sertions or deletions that disrupted the correct reading
frame. These sequences were included into the codon-
aligned nucleotide alignment using the CLUSTAL W pro-
file alignment option, and the resulting alignment ad-
justed manually to maintain the correct reading frame.
Gag
An alignment of positions 15 to 168 predicted amino
acid sequences obtained for the p24 gag region, accord-
ing to the numbering in MVP5180’s p24 amino acid se-
quence, is shown in Fig. 1A. The sequenced region was
highly conserved except in positions 47, 68, 77, and 114
to 126. As in group M p24, we observed a conserved
proline rich region (PP-X3-P-X-PP-X5-P). The similar ar-
ray, P-X4-P-X2-P-X5-P, conserved in HIV-1 group M, has
been reported as necessary for the incorporation of
cyclophilin A (CyPA) into HIV-1 viral particles and for
replication of HIV-1 group M. However, replication of
HIV-1 group O viruses does not depend on incorporation
of CyPA (Braaten et al., 1996). In addition to this pheno-
typic difference, the motif we observe in gag group O
FIG. 1. Predicted amino acid sequences from the 49 isolates. (A) Group O gag (p24) region sequences representative of phylogenetic clusters
bracketed in Fig. 3. See the letters to the left of the sequence names. In the gag alignment, the valine at position 49 associated with the O:C cluster
is marked in gray. (B) Group O V3 octameric tip major sequences. (C) Group O immunodominant region (IDR) consensus sequences and amino acid
variations in the 49 group O sequences; amino acids associated with a cluster are underlined. (D) Group M IDR consensus sequences: the 10 amino
acid positions which are not found in the group O IDR sequences are underlined.
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sequences contains more proline residues, suggesting
that this region has another role, at least, in group O
viruses. Alternatively, in group M another part of the viral
genome might be necessary for the incorporation of
CyPA. Thus, the proline-rich array, while necessary, is not
sufficient to explain the incorporation of CyPA which may
depend on other nonmapped mutations.
Finally, the major homology region (HMR) (Mammano
et al., 1994) is a 20-amino acid region conserved in all
primate lentiviruses, and has been described in group O
(Hackett et al., 1997). This protein core sequence is
absolutely conserved in all available sequences except
in BCF108, CM.CA9, CM.2902, CM6778, and YBF56 (not
shown). However, while the amino acid sequences are
relatively conserved the nucleic acid alignments show a
high degree of synonymous substitutions.
Envelope
The major amino acid sequences at the octameric tip
of the V3 loop are shown in Fig. 1B. This region was very
variable with a few sequence motifs present in different
strains, for example: 1 KIGPMAWY (9 strains), RIGP-
MAWY (15 strains), and KIGPLAWY (3 strains). The RIG-
PMAWY was the only motif previously found (Hunt et al.,
1997). However, in 33 of the 42 cases the last two amino
acids were WY (tryptophan-tyrosine) while VY (valine-
tyrosine) was present in BCF03, LY (leucine-tyrosine) in
YBF17, WL (tryptophan-leucine) in YBF22 and BCF09, WR
(tryptophan-arginine) in YBF15 and YBF35, WV (trypto-
phan-valine) in BCF06, and WI (tryptophan-isoleucine) in
YBF49. This region is so variable that within the two
couples BCF13/14 and YBF18/22, the partner shared only
the tetrameric tip. The only conserved V3 sequences are
the sequences from the mother (BCF100) and her baby
(BCF99).
The V3 tip tetramer sequence GPLA is represented
only twice in the 1998 Los Alamos National Laboratory
HIV Sequence Database (http://hiv-web.lanl.gov), but
was present in 5 of our group O sequences (BCF13,
BCF14, YBF18, YBF22, and YBF61), in addition to the 2
Equatorial Guinea sequences (193HA and 341HA). De-
rived from this tetramere was the GPLS motif in 5 se-
quences (BCF01, BCF11, YBF20, YBF49, and BCF111).
The most represented tetramere was the GPMA motif in
36 sequences among the 62 described to this date (58%).
The fourth motif was GPMS in 4 sequences (BCF03,
BCF09, BCF101, and YBF28). Finally 7 motifs were found
once (GPLR in BCF06, GPMT in YBF15, GPMV in YBF35,
GPMR in MVP5180, GGPLA in ESP_4, GSPMA in YBF37,
DPMA in CM6103, and GPTA in YBF56).
The gp41 immunodominant regions (IDR) amino acid
sequences are nearly identical for most of the 49 sam-
ples sequenced in this region, even if a large portion are
unique compared to those reported for other HIV-1 group
O isolates such as ANT70, VAU, or MVP5180 (not shown).
The distribution of variable positions in the IDR of gp41
shows that the variation was found in specific positions
such as amino acids 24 and 31, but that any of the strains
could show more than four differences to the consensus
shown in Fig. 1C. Position 24, inside the cysteine loop
(CKGRLVC), was also the most variable position found in
M group IDR sequences (Fig. 1D). Analysis of the C2-
gp41 regions show that there is a good conservation of
the glycosylation site previously described by Loussert-
Ajaka and Bibolet-Roche and respective co-workers ei-
ther in the V3 region or global envelope sequences
(Bibollet-Ruche et al., 1998; Loussert-Ajaka et al., 1995).
Phylogenetic analyses
Phylogenetic trees were constructed from nucleotide
alignments including all of the newly derived sequences
and the group O sequences retrieved from GenBank. To
make direct comparisons between the clustering of
strains in different genomic regions neighbor-joining
phylogenies were inferred from alignments including the
48 strains that were present in the three genomic regions
gag, C2-V3 env, and gp41 env, and the subset of these
available in the C2-gp41 region (Fig. 2). We were inter-
ested in comparing these group O phylogenies with
published work that has looked into the substructure of
this part of the HIV-1 tree. Based on pol and env se-
quence comparisons one group of researchers has iden-
tified a major phylogenetic cluster of viruses they named
“subtype A-O” that includes the first group O strain iden-
tified ANT70 (Mas et al., 1999; Quinones-Mateu et al.,
1998). Another group named this same cluster of viruses
“ANT70” as it includes this prototypic group O virus
(Janssens et al., 1999). The previously identified strains
(and their lineages) that characterized this O:A/ANT70
phylogenetic cluster are highlighted in with a  in Fig. 2,
and the most recent common ancestor of these strains is
indicated by the a  arrow in each tree. In the C2-V3,
gp41, and C2-gp41 phylogenies the majority of the newly
derived group O sequences cluster in this O:A phyloge-
netic cluster, while in the gag phylogeny fewer of the new
group O sequences are within this previously identified
cluster. Clearly though, this latter difference is not signif-
icant as the branch length leading to the ancestral node
of the O:A phylogenetic cluster indicated in Fig. 2 is very
short. Indeed in the gag, C2-V3, and gp41 phylogenies
there is no clear O:A phylogenetic cluster supported by
significant bootstrap values. Only in the C2-gp41 phylog-
eny can the previously identified O:A phylogenetic clus-
ter be identified with a high bootstrap value. Despite this
a congruent O:A phylogenetic cluster, regardless of how
well supported it is, can be clearly identified in the gag,
C2-V3, and gp41 phylogenies in Fig. 2. Indeed all of the
strains that share a most recent common ancestor with
the node marked by the black arrow are congruent in all
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four phylogenies (excluding YBF102 and YBF49 in the
C2-V3 phylogeny).
Distinct from the putative O:A cluster, there are also
significant phylogenetic clusters of related viruses (as
assessed by bootstrap values) that are congruent in all
four phylogenies in Fig. 2. In the top part of each of the
four phylogenies (Fig. 2) a distinct cluster of strains
supported by high bootstrap values (labeled as O:B) that
includes MVP5180, the second group O virus to be iden-
tified can be identified. While in the gag, C2-V3, and gp41
phylogenies another distinct cluster (labeled as O:C) can
be also identified. Note that this O:C phylogenetic cluster
cannot be present in the C2-gp41 env phylogeny be-
cause only one strain, YBF16, has been sequenced in
this region. In each of these two phylogenetic clusters
two sequences do not cluster in the O:B (YBF35) and O:C
(YBF102) phylogenetic clusters in the gp41 and C2-V3
phylogenies, respectively. Such discordant phylogenetic
relationships in trees inferred from different genomic
regions are an indication that recombination might have
occurred in the evolutionary history of these strains (Rob-
ertson et al., 1995). YBF37 is also of possible recombi-
nant ancestry under this criteria as it clusters with VAU
with significant bootstrap values in the C2-V3 and C2-
gp41 phylogenies but not in the gag phylogeny. It is
important to note that the root of the phylogenies in Fig.
2 was placed so as to maximize the distinction of the O:B
and O:C phylogenetic cluster; this approach can be con-
sidered conservative in favor of finding subtypes.
To investigate these phylogenetic relationships fur-
ther, more sequences were included in the analysis and
the more sophisticated phylogenetic inference method,
maximum likelihood was implemented. This time strains
were included that had been sequenced in at least two
of the different genomic regions gag, C2-V3, and gp41,
and the phylogenies midpoint rooted (Fig. 3). Again the
aim was to identify congruent phylogenetic clusters of
more closely related viruses. The same major O:A phy-
logenetic cluster, labeled as “A1” in the gag, C2-V3, and
gp41 phylogenies, exists in all four of the phylogenies
with almost all of the strains clustering within it (Fig. 3).
In these latter three phylogenies, the same phylogenetic
clusters (labeled “A2” and “A3”) form sister clades to A1.
Note, these phylogenetic clusters are not present in the
C2-gp41 tree because the strains forming the A2 and A3
clusters have not been sequenced across this region.
Together clusters A1 to A3 are labeled as O:A in Fig. 3.
This O:A phylogenetic cluster is highly congruent as the
same strains (apart from YB102, a probable recombinant)
cluster in it, in all four genomic regions.
The strains that form the O:B and O:C phylogenetic
clusters again cluster together in Fig. 3 as in Fig. 2, and
again YBF35 does not cluster in the O:B phylogenetic
cluster in the gp41 phylogeny. YBF49 is also now con-
sidered as a recombinant as its clustering within the O:B
phylogenetic cluster is not consistent. YBF35 and
YBF102 again exhibited discordant phylogenetic relation-
ships confirming their probable recombinant status.
However, YBF37 did not cluster with VAU in either the
gag, C2-V3, or gp41 phylogenies so it may not be recom-
binant. Additionally, several of the group O strains did not
cluster in the O:A, O:B, or O:C clusters, but rather re-
mained as distinct lineages whatever the region ana-
lyzed: ABT124, CM.4354, CM.6103, YBF37, and VAU (see
Figs. 2 and 3). When recombination frequency is high (as
it is for HIV) detecting specific recombinant strains can
be extremely difficult. There are very probably further
examples of recombinants between divergent strains
within these phylogenies, which would not be surprising
as dual infection by group O viruses undoubtedly occurs.
Two of the patients with linked infections (BCF13/BCF14
in the gag and gp41 phylogenies and YBF18/YBF22 in the
gp41 phylogeny) do not cluster together exclusively (Fig.
3), suggesting that these individuals have been dually
infected. Alternatively, these relationships could repre-
sent subsequent transmissions to other individuals by
one of the pairs or simply be the result of phylogenetic
error.
For the putative recombinants that have been se-
quenced in the C2-gp41 region further analysis can be
carried out. However, only for one of these (YBF102) do
relatively close ancestors of the recombinant “parental”
strains exist. Figure 4 shows a diversity plot for YBF102
in which pairwise distance comparisons were performed
in windows of 400 nucleotides incremented 10 nucleo-
tides across the C2-gp41 alignment. The diversity be-
tween these and the reference strains was found to vary
across the genome which is indicative of a recombinant
ancestry of YBF102. Four-sequence informative sites
analysis (Robertson et al., 1995) also yielded significant
support (P  0.001), as assessed by 10,000 permuta-
tions, for there being discordance between the distribu-
tion of informative sites supporting YBF102 clustering
with BCF13 or YBF16 (using MVP5180 as an outgroup).
Recently Yang and co-workers analyzed 19 group O
strains in the gp41 region and identified two distinct
clusters in their phylogeny which they consider as pos-
sible subtypes (Yang et al., 2000). Including these se-
quences into our gp41 alignment using the CLUSTAL W
profile alignment option, and editing this alignment to
maintain codon boundaries, the inferred phylogeny fur-
ther confirms the existence of the three major O clusters
O:A, O:B, and O:C, as assessed by bootstrap values, and
the presence of strains that do not fall into any of these
clusters (Fig. 5). Note that the increased support for the
O:A phylogenetic cluster in this phylogeny (84% of boot-
strap replicates) is presumably a result of the exclusion
of the putative recombinants already identified (YBF35,
YBF49, and YBF102).
No correlation was found among age, sex, country of
residence, or clinical status of infected individuals and
the group O phylogenetic clusterings we identify. Amino
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264 ROQUES ET AL.
acid sequence correlates with this group O phylogenetic
substructure were also investigated. The diversity of the
C2-V3 sequences is too high to allow the recognition of
any phylogenetic cluster-specific amino acid signature
as observed in M group. However, in the more con-
served CA sequences one valine in position 49 (Fig. 1A)
is specific to sequence cluster O:C. In the more con-
served gp41 sequences, there is no correlation of gp41
IDR sequences and phylogenetic clusters in the O group,
with the exceptions of (1) arginine in position 14 which
was associated with all strains of phylogenetic cluster
O:B, and (2) methionine in position 9, which was found
only in the sequences YBF16, YBF20, YBF97, and YBF102
which constitute the O:C phylogenetic cluster (residue
are underlined in Fig. 1C). Part of this region corresponds
to a cytotoxic T lymphocyte (CTL) epitope within cluster
O:A (ALETLIQNQQLL) (Dorn et al., 2000; Yang et al.,
2000). Serine in position 17 was associated with the A3
phylogenetic cluster (Fig. 3). Two other strains showed a
very unusual amino acid, glycine, in the first position.
However, all of the O sequences showed more than 10
differences with the group M consensus sequence. Out
of this region, cluster A2 (Fig. 3) was characterized by an
amino acid signature K576, F595, and S685. The latter
amino acid was in the B cell cluster II described by Yang
and co-workers (ELDEWA) and might be an indication of
a shift in immunoreactivity of this region for the A2
cluster (ELSEWA). Moreover some regions within gp41
revealed multiple deletions/insertions between positions
629 and 643 as previously noted (Yang et al., 2000), with
the particular case of YBF61 having an insertion of 9
amino acids.
To quantify the differences between the group O clus-
ters identified here and group M subtypes, genetic dis-
tances within and between group O clusters were com-
pared to those within and between group M subtypes.
Pairwise genetic distances, corrected using the HKY85
model of nucleotide substitution, were plotted (Fig. 6) for
comparisons of all of the group O strains in the gag,
C2-V3, and gp41 regions, and for the clusters O:A, O:B,
and O:C identified in Fig. 3 (strains known to be from
epidemiologically linked individuals and the strains con-
sidered as probable recombinants YBF35, YBF49, and
YBF102 were excluded). For comparison an alignment of
complete HIV-1 group M strains including 98 sequences
was obtained from the Los Alamos National Laboratory
HIV Sequence Database (http://hiv-web.lanl.gov) and the
same gag, C2-V3, and gp41 genomic regions were ana-
lyzed; intersubtype recombinants were excluded (Fig. 6).
As would be expected the diversity is highest in the
envelope region than for gag, and in the envelope region
highest across C2-V3 than for the gp41 region for both
HIV-1 groups O and M (Fig. 6). Interestingly, the diversity
among group O viruses in each of the genomic regions
analyzed is higher than that for group M with the only O
cluster showing comparable diversity to a subtype being
O:C.
To further investigate the “subtypeness” of group O a
statistic, the subtype diversity ratio (SDR), previously
used to compare the group M phylogenetic substructure
of the global pandemic to strains circulating in the Dem-
ocratic Republic of Congo (Rambaut et al., 2001), was
implemented by comparing the mean within-subtype
pairwise distance to the mean between-subtype pair-
wise distance for groups and O and M. The SDR statistic
was computed from maximum-likelihood phylogenies
(see Materials and Methods) for the three group O clus-
ters (O:A to O:C) versus group M phylogenies including
the nine subtypes M:A to M:D, M:F to M:H, and M:K. The
results were 0.28, 0.43, and 0.43 for group M and 0.57,
FIG. 4. Diversity plot comparing the genetic distance of the putative recombinant YBF102 to selected references from the C2-gp41 alignment.
Uncorrected pairwise genetic distances were calculated for a window of 400 nucleotides moved in increments of 10 nucleotides. The pairwise
distance was plotted against the midpoint of each window for each comparison. The x axis indicates the nucleotide positions along the alignment
after gaps had been stripped and removed from the alignment. The y axis denotes genetic distance (0.1  10% difference).
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0.65, and 0.42 for group O for the gag, C2-V3, and gp41
phylogenies. Other than for gp41 these SDR values rep-
resent a disparity close to that found by Rambaut and
co-workers, indicating that the majority of group O’s
phylogenetic substructure is quantifiably different to
group M showing no more subtype structure than phy-
logenetic trees simulated under a model of exponential
population growth (Pybus et al., 2000).
DISCUSSION
In this study we sequenced 49 strains, from four dif-
ferent genomic regions: gag, C2-V3, gp41, and a subset
from C2 to gp41. We wished to obtain a representative
sample of HIV-1 group O sequences by screening the
HIV infected population in Cameroon. Because 22 out of
the 25 French HIV-1 group O strains were isolated from
patients who originated, and were probably infected, in
Cameroon, we also included these sequences in the
study. However, the analysis of the different patient
groups (the majority of Cameroonian patients having
progressed to AIDS) highlighted the discrepancies be-
tween Cameroon and France in regard to analysis strat-
egies. In Cameroon, samples were obtained by a sys-
tematic survey of sera from 7353 HIV-1 immunodeficient
patients in the National Reference and Public Health
Laboratory of the Centre Pasteur in Yaounde. While pa-
tients living in France were identified through the normal
activities of diagnosis and care of HIV-infected persons
using both serological testing and nucleic acid assay.
These two different approaches explain the fact that
nearly all of the HIV-1 group O infections from Cameroon
were isolated from people with AIDS while the French
patients exhibited a range of clinical status. This is due
to African HIV-infected individuals tending not to be de-
tected prior to severe illness, rather than higher virulence
among the African cohort. We have no explanation for
observing 66% of those group O-infected in Cameroon to
be women, while the sex ratio was nearer to 50% for the
patients from France. We found only three patients from
France who were not natives of Cameroon which indi-
cates that at this time there is a low level transmission of
the group O viruses in the French population.
We show in the phylogenetic analysis of the 49 newly
derived HIV-1 group O strains, the existence of a major
group O:A phylogenetic cluster in four genomic regions,
in agreement with previous work in which a major group
O phylogenetic cluster was identified based on pol (Qui-
nones-Mateu et al., 1998) and env (Janssens et al., 1999;
Quinones-Mateu et al., 1998; Quinones-Mateu et al.,
1997) sequence comparisons. In addition we character-
ize a further two major group O phylogenetic clusters
(O:B and O:C). However, while these major group O
phylogenetic clusters could be identified that comprised
the same virus strains in each of the genomic regions
analyzed (the majority being O:A), the distinction be-
tween these clusters was unlike the substructure seen
within group M that led to the naming of subtypes (Myers
et al., 1992). At least for the gag and C2V3 phylogenies
this difference is significant as assessed by the SDR
statistic. Why the gp41 phylogeny should apparently ex-
hibit more “subtypeness” as assessed by the SDR statis-
tic remains to be determined when longer sequence
fragments are available for comparison. The group O
cluster, O:C, exhibits comparable genetic diversity to the
M subtypes (clusters O:A and O:B exhibited greater di-
versity, Fig. 6), and in the gag, C2-V3, and gp41 maxi-
mum-likelihood phylogenies (Fig. 3) cluster O:C has a
relatively long branch length leading to it, suggesting it
could be considered equivalent to a group M subtype.
FIG. 5. Phylogenetic relationships of the newly characterized viruses
to the previously described strains in the gp41 region and including the
19 newly derived strains (Yang et al., 2000), as inferred by neighbor-
joining from a nucleotide sequence alignment (see Materials and
Methods for further details). A total of 294 nucleotide sites remained
after sites including a gap were removed. The phylogeny is midpoint
rooted. Phylogenetic clusters referred to in the text are indicated to the
left of each strain name. The strain names in underlined are the strains
characterized by Yang and co-workers. The scale indicates substitu-
tions per site and refers to the horizontal branch lengths. The vertical
branch lengths are for clarity only.
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However, as the O:C cluster is tightly linked to the Cam-
eroonian population we propose that, for the moment,
none of the group O phylogenetic substructure should be
considered as equivalent to the group M-like subtype
structure, because the group O phylogeny (and our
knowledge of the origin of group O infections) indicates
they are unlikely to represent anything more than the
transmission network of infected individuals within Cam-
eroon. Thus, while we conclude that there is a high level
of congruency in neighbor-joining and maximum-likeli-
hood phylogenetic trees inferred from the different
genomic regions, we concur with Bibollet Ruche and
co-workers (1998) that the naming of any of these O
phylogenetic clusters is arbitrary and will probably only
be useful for the description of different parts of the O
phylogeny for strain characterization purposes. It is
clearly not a definitive nomenclature and should thus
remain tentative until complete genomes are available
for comparison (Robertson et al., 2000).
It was the existence of relatively long presubtype
branch lengths and the approximate equidistance be-
tween the subtypes that led to speculation of possible
different biological correlates with group M subtypes
(Myers et al., 1992). However, to date no conclusive
evidence for any biological correlate with subtypes has
been found other than geographical associations. Impor-
tantly, as more group M strains are included in the
phylogeny from Central Africa, particularly from the Dem-
ocratic Republic of Congo (DRC) (Vidal et al., 2000), the
distinct nature of the group M subtypes is becoming less
clear, as many of the new strains fall basal to the sub-
types defined on the global data (Rambaut et al., 2001).
Indeed, the group M subtypes seem to represent little
more than founder effects in the pandemic, i.e., the
chance exportation of strains from a continuum of diver-
sity in the DRC region to other African regions and to the
rest of the world. Thus, it now seems highly probable that
both group O and group M phylogenetic diversity was
generated in Central Africa prior to the pandemic’s exis-
tence; the Os in the Cameroon region, and the Ms in the
FIG. 6. Plot of pairwise genetic distance comparisons corrected using the HKY85 model of nucleotide substitution for all group O sequences;
phylogenetic clusters O:A, O:B, and O:C; between O clusters; all group M sequences; three group M subtypes (M:A, M:B, and M:C) and between M
subtypes for the genomic regions gag, C2-V3, and gp41. Strains identified as probable recombinants and strains from linked individuals were
excluded. The x axis indicates each phylogenetic cluster and the genomic region. The y axis denotes genetic distance (0.1  10% difference). Box
plots: the horizontal line in each box is the median for each set of comparisons. The rectangular boxes contain 50% of the data centered around this
median. The vertical lines either side of these boxes begin at the 10th percentile and end at the 90th percentile. Each data point below the 10th
percentile or above the 90th percentile is plotted individually.
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DRC region. This explains why the diversity among group
O viruses is higher than that among group M viruses.
Assuming a comparable rate of molecular evolution in
different HIV-1 lineages, the high diversity among the
group O viruses, greater than that of group M, suggests
this HIV-1 lineage has been circulating in Central Africa
for longer than group M. From this we might infer that
dating estimates of the 1930s for the most recent com-
mon ancestor of group M (Korber et al., 2000) will be an
approximate upper estimate for the most recent common
ancestor of group O. However it should be noted that
these estimates have not taken into account the influ-
ence of recombination on the assumption of a molecular
clock (Schierup and Hein, 2000), and so might be biased
in ways that are hard to predict (Worobey, 2001). Inter-
estingly, comparison of sequences from the earliest
group O strains obtained from a Norwegian who was a
sailor from 1961 to 1965 in which time he visited Central
Africa and his daughter (they both died in 1976 and virus
was obtained from autopsy materials) reveals little cor-
relation between branch length and time. This would
suggest that reliable dating of the emergence of group O
will be problematic as the Norwegian’s HIV strain does
not have a notably short branch length in contrast to the
earliest group M strain identified from a sample taken
1959 in Central Africa (Zhu et al., 1998).
The UNAIDS June 2000 Report on the Global HIV/AIDS
Epidemic estimates the adult population of Cameroon to
be approximately 6,723,000, 7.73% of which are esti-
mated to be HIV-positive (representing approximately
520,000 people). Thus, estimating 2 to 5% of these HIV-
positive people to be group O infected (Ayouba et al.,
2000), approximately 10,400 to 26,000 adults in Cam-
eroon will be infected by group O. Interestingly, Ayouba
and co-workers find no evidence for an increase in the
number of group O-infected individuals between 1994
and 1998, suggesting that this type of HIV-1 is endemic to
Cameroon (Ayouba et al., 2000, 2001). In contrast they
found the number of group M-infected individuals has
increased significantly. However, if the group O-infected
individuals in Cameroon who have progressed to AIDS
only represent some proportion of the total group O-
infected population there are possibly many more O-
infected individuals than have been identified. Also, the
way the group O infections are detected does not pick up
dual group O- and M-infected individuals, particularly as
dual infection will frequently be transient, again leading
to a potential underestimate of the number of group
O-infected people.
Importantly, while the overwhelming majority of known
group O viruses were isolated from patients residing in
Cameroon, group O strains have been found in Cam-
eroonians and their relatives in neighboring African
countries, Europe, and the United States. As there are no
biological reasons to believe HIV-1 group O viruses are
any less transmissible than group M viruses, it is very
possible group O could contribute more to the HIV/AIDS
pandemic in the future. A worrying development has
been the finding of recombinants between groups O and
M (Peeters et al., 1999; Takehisa et al., 1999; Yang et al.,
2000). As a high degree of sequence similarity is known
to be necessary for generation of a viable recombinant
genome it was previously predicted that O and M viruses
would be too divergent to generate viable recombinants.
Clearly this does not seem to be the case and given how
frequently recombinant variants are found (Robertson et
al., 1995), and how important certain recombinant forms
are in the pandemic (Carr et al., 1998; Robertson et al.,
2000), the possibility of an O/M circulating recombinant
forms arises. In conclusion, the characterization of diver-
gent HIV-1 sequences is vital to the continued monitoring
of the HIV pandemic, as well as for the evaluation of the
risks involved in blood transfusion, and at an individual
level the monitoring of patients with particular respect to
potential vaccine design and the success of antiviral
drugs.
MATERIALS AND METHODS
Patients
From 1994 to 1995 82 HIV-1 group O-positive samples
were detected in 3193 HIV-reactive samples in Cam-
eroon (a survey previously published by Mauclere and
co-workers (1997)). From 1997 to 1998 a further 60 group
O-positive samples were detected in 4160 HIV-1 group
M/O-reactive samples in Cameroon (Ayouba et al., 2001).
These sera were collected from blood donors, pregnant
women, and symptomatic patients hospitalized in 10
Cameroonian centers from Littoral to the north of the
country. The sera were then checked in the reference
center in Yaounde by using ELISA (indirect HIV-1 and
HIV-2 Genelavia, Sanofi Diagnostic Pasteur Paris,
France). The algorithm (Mauclere et al., 1997; Simon et
al., 1998) used to detect and confirm group M and O
infections consists of a second step of competitive ELISA
using group M-specific antigen (Wellcozyme Rec HIV-1;
Murex, Dartford, Kent, UK). All non-M-positive sera se-
lected by this method (i.e., CO/OD ratio below five) were
then submitted to a third selection round using third-
generation mixed ELISA (Enzygnost plus, Marburg, Ger-
many) able to detect group O-positive strains and a
Multispot rapid discriminate dot blot HIV-1/2. All the
positive sera were then tested by HIV-2 or HIV-1 Western
blot (New Lav Blot 1 or 2) according to the selection
round. Finally sera presenting more than a gag response
in HIV-1 Western Blot were screened for group O infec-
tion using a peptide competitive assay as described
(Mauclere et al., 1997; Simon et al., 1998). A second
blood sample was taken from 37 of the group O-infected
individuals and virus isolated from 24 of these (Table 1).
These Cameroonian strains are coded as CM.YBFXX.
Twenty-five group O strains isolated from patients
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monitored at the Bichat Hospital in Paris, France, as
described by Loussert-Ajaka and co-workers (1995),
were also obtained. The latter patients were mainly from
Paris and its suburb and constituted almost all of the
group O infections identified in France to date (Table 2).
The majority of these individuals (Mauclere et al., 1997)
originated by birth in Cameroon. The three others were
born in France, the French Indies, or Algeria. These 25
French strains are coded as FR.BCFXX.
In this study, there are two married couples who pre-
sumably have strains that represent epidemiologically
linked infections: YBF18/YBF22 and BCF13/BCF14. The
strain/patient BCF100 is from the baby of BCF99. Note
that this mother-child pair are different to those de-
scribed previously (Chaix-Baudier et al., 1998). BCF108a
and BCF108b (previously referred as patient 6052 in the
Observatoire des souches VIH-1 en France, ANRS Grant
SF/SL No. 4167) were taken from the same patient. Note
that YBF17 was sampled from the same individual as the
GenBank sequence CM.2549 and YBF19 was sampled
from the same individual as the published sequence
MP450 (Bibollet-Ruche et al., 1998).
The available clinical data of the patients are de-
scribed in Tables 1 and 2. Of the Cameroonian YBFXX
patients (Table 1), all exhibit AIDS symptoms except for
YBF46 and YBF56. By contrast, the BCFXX patients in
France exhibited variable clinical stages ranging from
asymptomatic to AIDS, and only 9 out of 25 were pro-
gressors at the time of sampling (Table 2).
Virus isolation, preparation of DNA, PCR, and
sequencing
Peripheral blood mononuclear cells (PBMC) were iso-
lated on Ficoll-Hypaque gradient in Cameroon from the
group O-seropositive patients. The isolation of the viral
strain was performed in Paris using the patient PBMC in
coculture with the lymphocyte of HIV-seronegative Cau-
casian donors. Viral replication was tested in culture
supernatant for 1 month using p24 ELISA (Elavia P24
polyclonal, Sanofi Diagnostics Pasteur). Positive super-
natants were frozen at 80°C for further studies.
DNA from cocultures and fresh PBMCs from infected
patients was extracted with phenol-chloroform. Cell DNA
(1 g) was amplified by using the primers described in
Table 3. Strains were amplified first using the XL-PCR kit
(PE Applied Biosystems, Courtabœuf, France) as de-
scribed (Simon et al., 1998) then nested PCR was per-
formed using the primers corresponding to the regions
specified either with Taq DNA pol (High Fidelity PCR
Master, Roche Diagnostic, Meylan, France) or Tfu DNA
pol (Appligene, Illkirch, France).
Direct sequencing was performed on PCR products
purified using the QIAquick PCR purification kit (Qiagen,
TABLE 1
Information for Patients Living in Cameroon (All Sequences Were from Patient PBMCs)
Strain/patient
identifier
Date of
sampling Sex
Age
(years) Clinical data
Patient’s
origin Culture
YBF15 1994 M 32 AIDS Yaounde´ 
YBF16 1994 M 35 AIDS Yaounde´ 
YBF17 1995 M 45 P. Tuberc. Yaounde´ 
YBF18 1995 F 37 AIDS Yaounde´ 
YBF19 1995 F 43 AIDS Yaounde´ 
YBF20 1995 F 20 AIDS Sakbayeme´ 
YBF22 1995 M 49 Asymptomatic Yaounde´ 
YBF26 1995 F 34 AIDS Yaounde´ 
YBF28 1995 F 35 AIDS Yaounde´ 
YBF37 1995 F 53 P. Tuberc. Sakbayeme´ 
YBF38 1995 F 33 P. Tuberc. Garoua 
YBF53 1995 F 42 AIDS Sosu-CAM 
YBF56 1995 F 38 Asymptomatic Sosu-CAM 
YBF32 1996 F 32 AIDS Yaounde´ 
YBF35 1996 F 36 AIDS Lowa 
YBF39 1996 F 54 AIDS Yaounde´ 
YBF44 1996 M 41 AIDS Garoua 
YBF46 1996 F 32 Asymptomatic Yaounde´ 
YBF49 1996 F 41 AIDS Ebolowa 
YBF51 1996 M 40 AIDS Yaounde´ 
YBF102 1997 M 52 AIDS Yaounde´ 
YBF61 1997 F 39 AIDS Sakbayeme´ 
YBF96 1997 M 33 AIDS Yaounde´ 
YBF97 1997 F 28 AIDS Yaounde´ 
Note. P. Tuberc., pulmonary tuberculoses.
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Courtaboeuf, France). Sequence reactions were per-
formed with the PRISM Ready Reaction Amplitaq FS dye
terminator (PE Applied Biosystems) with an automated
DNA sequencer (Applied Biosystems 373A or 377 se-
quencer). Sequencing was performed on both strands. A
C2-gp41 region was obtained by sequencing the over-
lapping C2 to V4, C4 to gp41 and gp41 fragments of the
env gene. All of the chromatograms were controlled for
TABLE 2
Information for Patients Living in France
Strain/patient
identifier
Date of
sampling Sex
Age
(years) Clinical data
Patient’s
origin Culture
CD4 cell
count/l
BCF03 1990 M 45 A3 Cameroon  97
BCF11 1991 F 68 A1 Cameroon  575
BCF07 1993 F 29 B2 Cameroon  384
BCF02 1994 F 38 C3 Cameroon  19
BCF06 1994 M 22 C3 Cameroon  10
BCF08 1994 F 22 A2 Cameroon  420
BCF12 1994 F 28 A2 Cameroon  337
BCF14 1994 M 37 A1 Cameroon a 600
BCF01 1995 M 44 B3 Cameroon a 91
BCF09 1995 F 38 A2 Cameroon  158
BCF13 1995 F 32 B3 Cameroon  154
BCF45 1997 F 18 A2 Cameroon  440
BCF57 1996 F 39 C3 Cameroon a 9
BCF58 1996 F 39 A2 North Africa  450
BCF100 1997 F 1 A1 Cameroon  ND
BCF101 1997 M 47 A3 French Indies  60
BCF59 1997 — 52 A2 Cameroon ND ND
BCF99 1997 F 32 ND Cameroon ND 200
BCF107 1998 M 34 B3 Cameroon  174
BCF108a/108b 1998 M 38 C3 Cameroon  90
BCF109 1998 F 34 B2 Cameroon ND 386
BCF111 1998 M 34 A1 France  832
BCF112 1998 F 61 A1 Cameroon  298
BCF113 1999 M 58 A1 Cameroon ND 324
BCF119 2000 F 33 A1 Cameroon  321
BCF120 2000 M 35 C Cameroon ND 36
Note. ND, not determined at date of sampling.
a Sequences from culture.
TABLE 3
XL-PCR primers
LTR5 V 500 AAAATCTCTAGCAGTGGCGCCCGAACAGG
LSiGi 500 TCAAGGCAAGCTTTATTGAGGCTTAAGCAG
V3 primers
V3 DUR_A 600 ATTCCAATACACTATTGTGCTCCA
V3 DUR_R 1100 AAAGAATTCTCCATGACAGTTAAA
gp41 primers
gp41 5_NE 1500 GAGAATTCTAAGTGCAGCAGGTAGCACTAT
gp41 3_NE 2225 GAGAATTCTAAGTTGCTCAAGAGGTGGTA
“Junction” primers
V3 I 900 ATA YTH AAT GGR ACA CTC TCT
gp41 J 1650 CAG GCG AGC TCG GAG YTG T
gp41 PR_3 1800 TTA GGM GYT GCT GAT TCT
gag primers
gag CAM_5 350 GAGAATTCTAAATGCATGGGTAAAGGCAGT
gag CAM_I_5 400 GAGAATTCTAAATGCATGGGTAAAGGCAGT
gag CAM_I_3 690 GAGAATTCAGTAGCTTGCTCAGCTCTTAAT
gag CAM_3 800 GAGAATTCATCCATTT(CT)CTATAGATGTCTCCT
270 ROQUES ET AL.
accuracy before confirmation of a sequence. Any posi-
tions with sequence ambiguities were given the appro-
priate IUPAC designation.
Nucleotide sequence accession numbers
The full set of sequences are available at the EMBL or
GenBank sequence databases with Accession Numbers
AJ238861 to AJ238875 (gag, C2-V3, and gp41 sequences);
AJ236390 to AJ236451 (gag and gp41 sequences);
AJ241460 to AJ241477 (C2-V3 sequences); and AJ133055
to AJ133077 (C2-gp41 sequences); AJ298123 to AJ298128
(gag sequences).
Phylogenetic analysis
Accession numbers for all available HIV-1 group O
strains homologous to the gag, C2-V3, gp41, and C2-gp41
regions were retrieved from the GenBank sequence da-
tabase using the BLAST program (http://ncbi.nlm.nih.
gov/blast). These accession numbers were used to re-
trieve sequences from GenBank using Batch-Entrez
(http://ncbi.nlm.nih.gov/entrez). CLUSTALW was used to
align the inferred amino acid sequences of these Gen-
Bank and newly derived strains (Thompson et al., 1994).
Where necessary the amino acid sequence alignment
was improved and poorly aligned regions excluded. The
resulting amino acid-based alignment was used as an
exact guide for the placing of insertions and deletions in
a nucleotide alignment. Gap-containing sites were re-
moved prior to all analysis.
All pairwise distance estimates and phylogenetic
trees were inferred using PAUP version 4 (Swofford,
1999). Distance-matrix-based trees were constructed
with the neighbor-joining method (Saitou and Nei, 1987)
using the HKY85 model of nucleotide substitution (Hase-
gawa et al., 1985). The reliability of the branching order
was estimated by performing 1000 bootstrap replicates,
again using the HKY85 model. Maximum-likelihood trees
were also constructed using the HKY85 model of nucle-
otide substitution incorporating an estimate of the tran-
sition/transversion ratio and an alpha shape parameter
(using eight discrete categories of rate variation) for a
gamma distribution of rate heterogeneity among sites,
both estimated on the neighbor-joining tree. The neigh-
bor-joining tree topology was used as the starting tree in
a heuristic search using TBR branch swapping to search
for the maximum-likelihood tree.
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